๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cyclosporin A inhibits T cell-mediated augmentation of mouse natural killer activity

โœ Scribed by R.H. Yanagihara; W.H. Adler

Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
548 KB
Volume
4
Category
Article
ISSN
0162-3109

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Antibody-induced augmentation of murine
Antibody-induced augmentation of murine natural killer cell activity
โœ Michael J. Brunda; Ronald B. Herberman; Howard T. Holden ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 671 KB

## Abstract Antibodies reactive with effector cells were shown to augment the cytotoxicity of spleen cells from athymic nude and euthymic mice. The addition of alloantibody to the assay or pretreatment of the effector cells with alloantibody resulted in increased cytotoxicity against the human cell

Interferon-independent, lectin-induced a
Interferon-independent, lectin-induced augmentation of murine natural killer cell activity
โœ Michael J. Brunda; Luigi Varesio; Ronald B. Herberman; Howard T. Holden ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 1017 KB

## Abstract The ability of lectins to augment natural killer (NK) cell activity was demonstrated using splenic effector cells from athymic nude mice. The addition of __Helix pomatia__ agglutinin to the assay or pretreatment of the effector cells with lectin resulted in increased cytotoxicity agains

Activation of mouse macrophages by pyran
Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity
โœ Paolo Puccetti; Angela Santoni; Carlo Riccardi; Howard T. Holden; Ronald B. Herb ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 633 KB

## Abstract Inoculation of mice with pyran copolymer resulted in activation of natural killer (NK) cells as well as macrophages. Conditions optimal for the boosting of NK activity seemed to differ from those optimal for macrophage activation as assessed by cytostasis of tumor target cells. Peak lev